These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38715705)

  • 1. Medium-Chain Triglycerides (MCTs) for the Symptomatic Treatment of Dementia-Related Diseases: A Systematic Review.
    Meer N; Fischer T
    J Nutr Metab; 2024; 2024():9672969. PubMed ID: 38715705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To Keto or Not to Keto? A Systematic Review of Randomized Controlled Trials Assessing the Effects of Ketogenic Therapy on Alzheimer Disease.
    Grammatikopoulou MG; Goulis DG; Gkiouras K; Theodoridis X; Gkouskou KK; Evangeliou A; Dardiotis E; Bogdanos DP
    Adv Nutr; 2020 Nov; 11(6):1583-1602. PubMed ID: 32597927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emulsification Increases the Acute Ketogenic Effect and Bioavailability of Medium-Chain Triglycerides in Humans: Protein, Carbohydrate, and Fat Metabolism.
    Courchesne-Loyer A; Lowry CM; St-Pierre V; Vandenberghe C; Fortier M; Castellano CA; Wagner JR; Cunnane SC
    Curr Dev Nutr; 2017 Jul; 1(7):e000851. PubMed ID: 29955713
    [No Abstract]   [Full Text] [Related]  

  • 5. Medium-chain triglycerides may improve memory in non-demented older adults: a systematic review of randomized controlled trials.
    Giannos P; Prokopidis K; Lidoriki I; Triantafyllidis KK; Kechagias KS; Celoch K; Candow DG; Ostojic SM; Forbes SC
    BMC Geriatr; 2022 Oct; 22(1):817. PubMed ID: 36273115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease.
    Sharma A; Bemis M; Desilets AR
    Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):409-14. PubMed ID: 24413538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial.
    Rebello CJ; Keller JN; Liu AG; Johnson WD; Greenway FL
    BBA Clin; 2015 Jun; 3():123-5. PubMed ID: 26675661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis.
    Sun L; Ye KX; Wong HLK; Wang L; Lim SL; Chao YX; Zhang C; Yap KZ; Feng L
    J Alzheimers Dis; 2023; 94(2):441-456. PubMed ID: 37248908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis.
    Castro CB; Dias CB; Hillebrandt H; Sohrabi HR; Chatterjee P; Shah TM; Fuller SJ; Garg ML; Martins RN
    Nutr Rev; 2023 Aug; 81(9):1144-1162. PubMed ID: 36633304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation of Regular Diet With Medium-Chain Triglycerides for Procognitive Effects: A Narrative Review.
    Shcherbakova K; Schwarz A; Apryatin S; Karpenko M; Trofimov A
    Front Nutr; 2022; 9():934497. PubMed ID: 35911092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High versus low medium chain triglyceride content of formula for promoting short-term growth of preterm infants.
    Perretta L; Ouldibbat L; Hagadorn JI; Brumberg HL
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD002777. PubMed ID: 33620090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies.
    Avgerinos KI; Egan JM; Mattson MP; Kapogiannis D
    Ageing Res Rev; 2020 Mar; 58():101001. PubMed ID: 31870908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ketogenic Diet and Alzheimer's Disease.
    Hersant H; Grossberg G
    J Nutr Health Aging; 2022; 26(6):606-614. PubMed ID: 35718870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognition and Synaptic-Plasticity Related Changes in Aged Rats Supplemented with 8- and 10-Carbon Medium Chain Triglycerides.
    Wang D; Mitchell ES
    PLoS One; 2016; 11(8):e0160159. PubMed ID: 27517611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refueling the post COVID-19 brain: potential role of ketogenic medium chain triglyceride supplementation: an hypothesis.
    Juby AG; Cunnane SC; Mager DR
    Front Nutr; 2023; 10():1126534. PubMed ID: 37415915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease.
    Ota M; Matsuo J; Ishida I; Takano H; Yokoi Y; Hori H; Yoshida S; Ashida K; Nakamura K; Takahashi T; Kunugi H
    Neurosci Lett; 2019 Jan; 690():232-236. PubMed ID: 30367958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.
    Reger MA; Henderson ST; Hale C; Cholerton B; Baker LD; Watson GS; Hyde K; Chapman D; Craft S
    Neurobiol Aging; 2004 Mar; 25(3):311-4. PubMed ID: 15123336
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.